The excretion of tyramine sulphate after challenge with an oral load of tyramine was assessed in recently detoxified, clinically depressed alcoholics and a matched group of major depressives. Tyramine excretion in the alcohol group (mean 5.95 ± 3.28 mg/3 h SD) was in the range previously observed in controls and was significantly higher than in the matched depressives (mean 3.43 ± 2.37 mg/3 h SD). Tyramine sulphate excretion has been suggested as a genetic vulnerability marker for major depression. This study suggests that depression associated with alcohol withdrawal is not characterised by decreased tyramine sulphate excretion after oral tyramine challenge, such decreased conjugation only being present, perhaps, in those patients with pre- existing endogenous depressive vulnerability. Although a genetic link between alcoholism and depression exists, these results support the absence of such a link to major depression.
Aghabeigi B., Feinmann C., Glover V., Goodwin B., Hannah P., Harris M., Sandler M., Wasil M. (1993) Tyramine conjugation deficit in patients with chronic idiopathic temporomandibular joint and orofacial pain. Pain54:159-163
2.
Berrettini W., Post R. ( 1984) GABA in affective illness. In Post R, Ballenger J (eds), Neurobiology of mood disorders. Williams and Wilkins, Baltimore, MD, pp. 673-685
3.
Bohman M., Cloninger R., Sigvardsson S., von Knorring A.-L (1987) The genetics of alcoholism and related disorders . J Psychiatr Res21: 447-452
4.
Bonham Carter S., Sandler M., Goodwin B.L., Sepping P., Bridges P.K. (1978) Decreased urinary output of tyramine and its metabolites in depression. Br J Psychiatr132:125-132
5.
Bonham Carter S.M., Reveley M.A., Sandler M., Dewhurst J., Little B.C., Hayworth J., Priest R.G. (1980) Decreased urinary output of conjugated tyramine is associated with lifetime vulnerability to depressive illness. Psychiatr Res3:13-21
6.
Bonham Carter S.M., Glover V., Sandler M., Gillman P.K. (1981) Human platelet phenylsulphotransferase; separate control of the two forms and activity range in depressive illness. Clin Chim Acta117: 333-344
7.
Brambilla F., Smeraldi E., Bellodi L., Sacchetti E., Muller E.E. (1980) Neuroendocrine correlates and monoaminergic hypotheses in primary affective disorders. In Brambilla F, Racagni G, Dewild D (eds), Progress in psychoneuroendocrinologyElsevier/North Holland, New York, pp. 235-245
8.
Davis B.A., Boulton A.A., Yu P.H., Durden D.A., Bowen R.C., Keegan D.L., Blackshaw S., d'Arcy C.D., Remillard A.J., Dayal N., Shrikhande S., Saleh S. (1991) Deuterium-labelled p-tyramine challenge test and phenosulfotransferase activity in depressed patients — failure to replicate decreased p-tyramine conjugation in depression. Prog Neuro Psychopharmacol Biol Psychiatr15: 241-237
9.
Ernouf D., Compagnon P., Lothion P., Narcisse G., Bernard J.Y., Daost M. (1993) Platelet 3H 5-HT uptake in descendants from alcoholic patients: a potential risk factor for alcohol dependence. Life Sci52: 989-995
10.
Faraj B.A., Lenton J.D., Kutner M., Camp V.M., Stammers T.W., Lee S.R., Lolies P.A., Chandora D. (1987) Prevalence of low monoamine oxidase function in alcoholism. Alcoholism11: 464-467
11.
Grove W., Andreasen N., Winokur G., Clayton P., Endicott J., Coryell W. (1987) Primary and secondary affective disorders: unipolar patients compared in familial aggregation. Comp Psychiatr28: 113-126
12.
Gudeman J.E., Schatzberg A.F., Sampson J.A., Orsulak P.J., Cole J.O., Schildkraut J.J. (1982) Towards a biochemical classification of depressive disorders. VI. Platelet MAO activity and clinical symptoms in depressed patients . Am J Psychiatr139: 630-633
13.
Hale A.S. (1993) The use of tyramine sulphate excretion. Biogenic Amines9: 403-430
14.
Hale A.S., Walker P.L., Bridges P.K., Sandler M. (1986) Tyramine conjugation deficit as a trait marker for endogenous depressive illness. J Psychiatr Res20: 251-261
15.
Hale A.S., Sandler M., Hannah P., Bridges P.K. (1989) Tyramine conjugation test for prediction of treatment response in depressed patients. Lanceti: 234-236
16.
Hale A.S., Sandler M., Hannah P., Glover V., Bridges P.K. (1991) Tyramine conjugation test distinguishes unipolar from bipolar depressed patients and controls. J Psychiatr Res25:185-190
17.
Harris E., Noyes R., Crowe R., Chaudry D. (1983) Family study of agoraphobia: report on a pilot study. Arch Gen Psychiatr40: 1061-1064
18.
Harrison W.M., Cooper T.B., Stewart J.W., Quitkin F.M., McGrath P.J., Liebowitz M.R., Rabkin J.R., Markowitz J.S., Klein D.F. (1984) The tyramine challenge test as a marker for melancholia . Arch Gen Psychiatr41: 681-685
19.
Hoffman P.L., Tabakoff B. (1990) Ethanol and guanine nucleotide binding proteins: a selective interaction. FASEB J4: 2612-2622
20.
Jarman J., Fernandez M., Davies P T G, Glover V., Steiner T.J., Thompson C., Clifford Rose F., Sandler M. (1990) High incidence of endogenous depression in migraine: confirmation by tyramine test. J Neurol Neurosurg Psychiatr53: 573-575
21.
Littlewood J.T., Glover V., Sandler M. (1985) Red wine contains a potent inhibitor of phenylsulphotransferase . Br J Clin Pharmacol19: 275-278
22.
Loosen P.T., Prange A.J. (1982) The TRH-induced TSH response: a possible neuroendocrine marker. In Usdin E, Hanin I (eds), Biological markers in psychiatry and neurology . Pergamon Press, Oxford, pp. 279-290
23.
Matussek N., Ackenheil M., Hippius H., Muller P., Schroder H.T., Schultes H., Wasilewski B. (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatr Res2: 25-36
24.
Meltzer H., Lowy M. ( 1987) The serotonin hypothesis of depression. In Meltzer H (ed.), Psychopharmacology: the third generation of progress. Raven Press, New York, pp. 513-552
25.
Radouco-Thomas S., Garcin F., Murthy M R V, Faure N., Lemay A., Forest J.C., Radouco-Thomas C. (1984) Biological markers in major psychosis and alcoholism: phenotypic and genotypic markers. J Psychiatr Res18: 513-539
26.
Rausch J.L., Monteiro M.G., Schuckit M.A. (1991) Platelet serotonin uptake in men with family histories of alcoholism. Neuropsychopharmacology4: 83-86
27.
Reveley A.M., Bonham Carter S.M., Reveley M.A., Sandler M. (1982) A genetic study of platelet phenolsulphotransferase activity in normal and schizophrenic twins. J Psychiatr Res17: 303-307
28.
Roy A., DeJong J., Lamparski D., George T., Linnoila M. (1991) Depression among alcoholics: relationship to clinical and cerebrospinal fluid variables. Arch Gen Psychiatr48: 428-432
29.
Sandler M., Bonham Carter S., Cuthbert M.F., Pare C B M (1975) Is there an increase in monoamine oxidase activity in depressive illness? Lanceti: 1045-1049
30.
Schuckit M. (1986) Genetic and clinical implications of alcoholism and affective disorders. Am J Psychiatr143: 140-147
31.
Steinberg J.L., Orsulak P.J., Raese J.D., Gregory R.R., Zielinski M.H., Wittman P.D. (1993) Effects of tricyclic antidepressant treatment on tyramine-O-sulphate excretion in depressed patients. J Affective Disord27: 29-34
32.
Suranyi-Cadotte B.E., Donigier M., Lafaille F., Luthe L. (1989) Platelets of alcoholics and of subjects genetically at risk for alcoholism share the same abnormality of imipramine binding sites . Br J Addiction84: 437-438
33.
Van Loon J., Weinshilboum R.M. (1984) Human platelet phenol sulfotransferase: familial variation in thermal stability of the TS form. Biochem Genet22: 997-1014
34.
Winokur G. (1985) The validity of neurotic-reactive depression: new data and reappraisal. Arch Gen Psychiatr42: 1116-1122
35.
Winokur G. (1987) Family (genetic) studies in neurotic depression . J Psychiatr Res21: 357-363
